MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies Major milestone achieved with new…
Categorie
2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Article 223-16 of the General…
September 8, 2023
MaaT Pharma Announces European Medicines Agency Granted MaaT033 Orphan Drug Designation Aiming to Improve Overall Survival in Patients Undergoing Hematopoietic…
September 7, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Article 223-16 of the General…
August 2, 2023
MaaT Pharma Provides Second Quarter 2023 Business Update and Reports Financial Results Data presented at 49th Annual Meeting of EBMT…
July 27, 2023
[image_with_animation image_url=”10517″ animation=”Grow In” hover_animation=”none” alignment=”center” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”50%” max_width_mobile=”default” img_link=”https://www.ebmt.org/annual-meeting-2023″] MaaT Pharma Announces Publication of Results in eClinicalMedicine…
July 26, 2023
MaaT Pharma Joins Microbiome Therapeutics Innovation Group Lyon, France, July 20, 2023 6:00 pm CET – MaaT Pharma (EURONEXT: MAAT…
July 20, 2023
MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux Lyon, France, July 13, 2023 6:00 pm…
July 13, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Article 223-16 of the General…
July 6, 2023
MaaT Pharma Announces New Appointments to the Board and Executive Team Appointments to the Board of Directors and Executive team,…
June 21, 2023
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
Ressources
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.